The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.
What Is The Expected Market Size Of The Oral Proteins And Peptides Market From 2026 To 2030?
The oral proteins and peptides market has experienced rapid expansion over recent years. This market is projected to expand from $1.56 billion in 2025 to $1.91 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 22.5%. Historically, this expansion has been driven by several factors, including the challenge of limited oral bioavailability of proteins and peptides, a historical reliance on injectable formulations, the rising prevalence of diabetes and gastrointestinal disorders, advancements in research concerning peptide therapeutics, and the granting of regulatory approvals for early oral peptide drugs.
The market for oral proteins and peptides is projected to experience rapid expansion over the coming years. This market is forecast to reach a valuation of $4.26 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 22.2%. Several factors are driving this growth during the projection period, including the introduction of innovative oral protein delivery technologies, the broadening scope of chronic disease management initiatives, the increasing uptake of tailored and multi-drug treatments, higher healthcare spending directed at metabolic and hormonal conditions, and the incorporation of digital tools for patient adherence and monitoring. Key trends anticipated for this period encompass the growing use of oral insulin and various therapeutic peptides, the expansion of personalized medicine and targeted oral protein interventions, an intensified focus on therapies for gastrointestinal disorders, the wider availability of oral protein formulations addressing diabetes and metabolic conditions, and innovations in long-acting and combination oral protein products.
Download the Free Sample Report to Explore Key Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=19629&type=smp
What Key Drivers Are Influencing The Growth Of The Oral Proteins And Peptides Market?
The expansion of the biopharmaceutical sector is projected to fuel the advancement of the oral proteins and peptides market in the future. This industry is a specialized segment within the wider pharmaceutical domain, dedicated to the creation, manufacture, and commercialization of medications sourced from biological entities. The increase in the biopharmaceutical industry’s scale is attributed to breakthroughs in biotechnology, a rising need for individualized medical treatments, the increasing commonness of chronic illnesses, and heightened investment in research and development. Within biopharmaceuticals, oral proteins and peptides present an opportunity for administering therapies without invasive procedures, thereby improving patient adherence and lessening the necessity for injections. They are capable of targeting specific conditions, exhibiting improved stability and uptake within the gastrointestinal tract. As an illustration, figures from October 2025 by the UK’s Bioscience and Health Technology Sector indicate that during 2023/2024, the UK life sciences industry contained 6,170 businesses operating under 7,320 companies. These enterprises provided employment for 359,600 individuals and achieved a turnover of £146.9 ($169.69) billion. Consequently, the expanding biopharmaceutical industry is a key factor propelling the growth of the oral proteins and peptides market.
Which Segments Are Included In The Analysis Of The Oral Proteins And Peptides Market?
The oral proteins and peptides market covered in this report is segmented –
1) By Drug Type: Linaclotide, Calcitonin, Insulin, Plecanatide, Octreotide
2) By Biological Target: Guanylate Cyclase-C (GC-C), Insulin Receptor, Other Biological Targets
3) By Mechanism Of Action: Receptor Stimulation, Substrate Degradation, Other Mechanisms Of Action
4) By Application: Gastrointestinal Disorders, Bone Disease, Neurological Disorders, Diabetes, Metabolic Disorders, Hormonal Disorder, Cancer
Subsegments:
1) By Linaclotide: Indications For Irritable Bowel Syndrome (IBS), Indications For Chronic Idiopathic Constipation (CIC)
2) By Calcitonin: Calcitonin-Salmon, Synthetic Calcitonin, Calcitonin for Osteoporosis Treatment
3) By Insulin: Long-Acting Insulin, Combination Insulin Products, Oral Insulin Formulations
4) By Plecanatide: Indications For Chronic Idiopathic Constipation (CIC), Indications For Irritable Bowel Syndrome With Constipation (IBS-C)
5) By Octreotide: Long-Acting Octreotide Formulations, Short-Acting Octreotide Formulations, Indications For Acromegaly And Neuroendocrine Tumors
Which Trends Are Impacting The Growth Of The Oral Proteins And Peptides Market?
Major companies engaged in the oral proteins and peptides market are concentrating on innovating formulation technologies to improve peptide stability, absorption, and bioavailability in oral dosage forms. These advancements are designed to address traditional obstacles such as enzymatic degradation and poor absorption in the digestive system. For example, in August 2025, BioMed X, a biomedical research institute located in Germany, commenced a new collaboration with Novo Nordisk, a pharmaceutical company based in Denmark, to expedite the progress of next-generation oral peptide delivery technologies. This partnership intends to investigate new molecular strategies and delivery methods to enable the creation of safe, effective, and user-friendly oral peptide therapeutics. By merging BioMed X’s early-stage research capabilities with Novo Nordisk’s specialized knowledge in peptide-based medicines, the joint effort aims to further cutting-edge oral drug delivery solutions and broaden the therapeutic applicability of peptide medicines across metabolic and chronic illnesses.
Which Key Industry Participants Are Active In The Oral Proteins And Peptides Market?
Major companies operating in the oral proteins and peptides market are Pfizer Inc., Merck & Co. Inc., AbbVie Inc., Sanofi S.A., AstraZeneca PLC, Eli Lilly and Company, Novo Nordisk A/S, Ipsen S.A., Biocon Limited, Xeris Pharmaceuticals Inc., Adocia S.A., Zealand Pharma A/S, Diabetology Ltd., Oramed Pharmaceuticals Inc., Palatin Technologies Inc., Entera Bio Ltd.
Read the full oral proteins and peptides market report here:
https://www.thebusinessresearchcompany.com/report/oral-proteins-and-peptides-global-market-report
Which Region Is Expected To Register The Fastest Growth In The Oral Proteins And Peptides Market?
North America was the largest region in the oral proteins and peptides market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the oral proteins and peptides market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Tailored Oral Proteins And Peptides Market Research Report For Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=19629&type=smp
Browse Through More Reports Similar to the Global Oral Proteins And Peptides Market 2026, By The Business Research Company
Oral Biologics And Biosimilar Drug Market Report 2026
Oral Contraceptive Pills Market Report 2026
https://www.thebusinessresearchcompany.com/report/oral-contraceptive-pills-global-market-report
Oral Thin Films Market Report 2026
https://www.thebusinessresearchcompany.com/report/oral-thin-films-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model